Comprehensive impurity profiling and LC–MS/MS-based structural elucidation of degradation products in xanomeline and trospium chloride using a stability-indicating RP-UPLC method

Xanomeline and trospium chloride are administered as combination therapy, necessitating reliable analytical methods for their assessment. Although several analytical approaches have been described for their simultaneous determination, none have addressed concurrent analysis of both drugs with related-impurity profiling and degradation-product characterization. To address this gap, a UPLC-LC-MS/MS method was developed and validated for the concurrent analysis of xanomeline, trospium chloride, and their related impurities, alongside characterization of stress-induced degradation products within a single chromatographic run. Optimal separation was achieved on an XBridge C18 column using gradient mode with 0.1% formic acid buffer and acetonitrile at a flow rate of 0.5 mL/min with UV detection at 235 nm. Linearity was established over concentration ranges of 50–300 µg/mL for xanomeline, 10–60 µg/mL for trospium chloride, 0.100–0.360 µg/mL for xanomeline-related impurities, and 0.020–0.072 µg/mL for trospium chloride-related impurities, with coefficients of determination (R2) > 0.998. The LOD and LOQ for xanomeline and its related impurities were 0.033 and 0.100 µg/mL, respectively, while those for trospium chloride and its related impurities were 0.0066 and 0.020 µg/mL. Accuracy ranged from 98.1% to 101.7%, and precision showed %RSD values below 2%. Robustness studies indicated negligible effects from deliberate variations in analytical parameters. Stress degradation experiments demonstrated pronounced degradation under oxidative, hydrolytic, and acidic conditions with mass balance values of 97.9%-99.6%. LC-MS/MS characterization enabled identification of major degradation products and degradation pathways. The method demonstrated high accuracy, robustness, and sensitivity, supporting its application in routine quality and stability assessments of xanomeline and trospium chloride formulations.

Authors

Publication Details

Journal
Figshare
Published
2026-11-18
DOI
https://doi.org/10.6084/m9.figshare.35049239
Primary Topic
Analytical Methods in Pharmaceuticals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comprehensive impurity profiling and LC–MS/MS-based structural elucidation of degradation products in xanomeline and trospium chloride using a stability-indicating RP-UPLC method

Anoop Bodapati, Bangaraiah Pagala
4 links
Figshare
Analytical Methods in Pharmaceuticals
article

Comprehensive impurity profiling and LC–MS/MS-based structural elucidation of degradation products in xanomeline and trospium chloride using a stability-indicating RP-UPLC method

Anoop Bodapati, Bangaraiah Pagala
article en

Abstract

Xanomeline and trospium chloride are administered as combination therapy, necessitating reliable analytical methods for their assessment. Although several analytical approaches have been described for their simultaneous determination, none have addressed concurrent analysis of both drugs with related-impurity profiling and degradation-product characterization. To address this gap, a UPLC-LC-MS/MS method was developed and validated for the concurrent analysis of xanomeline, trospium chloride, and their related impurities, alongside characterization of stress-induced degradation products within a single chromatographic run. Optimal separation was achieved on an XBridge C18 column using gradient mode with 0.1% formic acid buffer and acetonitrile at a flow rate of 0.5 mL/min with UV detection at 235 nm. Linearity was established over concentration ranges of 50–300 µg/mL for xanomeline, 10–60 µg/mL for trospium chloride, 0.100–0.360 µg/mL for xanomeline-related impurities, and 0.020–0.072 µg/mL for trospium chloride-related impurities, with coefficients of determination (R2) > 0.998. The LOD and LOQ for xanomeline and its related impurities were 0.033 and 0.100 µg/mL, respectively, while those for trospium chloride and its related impurities were 0.0066 and 0.020 µg/mL. Accuracy ranged from 98.1% to 101.7%, and precision showed %RSD values below 2%. Robustness studies indicated negligible effects from deliberate variations in analytical parameters. Stress degradation experiments demonstrated pronounced degradation under oxidative, hydrolytic, and acidic conditions with mass balance values of 97.9%-99.6%. LC-MS/MS characterization enabled identification of major degradation products and degradation pathways. The method demonstrated high accuracy, robustness, and sensitivity, supporting its application in routine quality and stability assessments of xanomeline and trospium chloride formulations.

Figshare
Good health and well-being
Analytical Methods in Pharmaceuticals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon